{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:01:56Z","timestamp":1789639316149,"version":"4.0.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525061"],"award-info":[{"award-number":["82525061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377077"],"award-info":[{"award-number":["22377077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82225045"],"award-info":[{"award-number":["82225045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82530106"],"award-info":[{"award-number":["82530106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77658-y","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:55Z","timestamp":1789635775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure-based design of subtype-selective psychedelic analogs"],"prefix":"10.1038","volume":"17","author":[{"given":"Huiqiong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9076-2946","authenticated-orcid":false,"given":"Bing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7371-4512","authenticated-orcid":false,"given":"Jing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7279-2893","authenticated-orcid":false,"given":"Zhi-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4176-8844","authenticated-orcid":false,"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-2682","authenticated-orcid":false,"given":"Jianjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"77658_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schioth, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 16, 829\u2013842 https:\/\/doi.org\/10.1038\/nrd.2017.178 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77658_CR2","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1021\/acs.jmedchem.8b00836","volume":"62","author":"M Vass","year":"2019","unstructured":"Vass, M. et al. Aminergic GPCR-ligand interactions: a chemical and structural map of receptor mutation data. J. Med. Chem. 62, 3784\u20133839 https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00836 (2019).","journal-title":"J. Med. Chem."},{"key":"77658_CR3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41573-025-01139-y","volume":"24","author":"JS Lorente","year":"2025","unstructured":"Lorente, J. S. et al. GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 24, 458\u2013479 https:\/\/doi.org\/10.1038\/s41573-025-01139-y (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77658_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cell.2018.01.001","volume":"172","author":"Y Peng","year":"2018","unstructured":"Peng, Y. et al. 5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology. Cell 172, 719\u2013730 https:\/\/doi.org\/10.1016\/j.cell.2018.01.001 (2018).","journal-title":"Cell"},{"key":"77658_CR5","doi-asserted-by":"publisher","unstructured":"Fan, L. Y. et al. Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands. Nat. Commun. 11. https:\/\/doi.org\/10.1038\/s41467-020-14884-y. (2020).","DOI":"10.1038\/s41467-020-14884-y"},{"key":"77658_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.aan5468","volume":"358","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science 358, 381\u2013386 https:\/\/doi.org\/10.1126\/science.aan5468 (2017).","journal-title":"Science"},{"key":"77658_CR7","doi-asserted-by":"publisher","unstructured":"Arroyo-Urea, S. et al. A bitopic agonist bound to the dopamine 3 receptor reveals a selectivity site. Nat Commun 15. https:\/\/doi.org\/10.1038\/s41467-024-51993-4. (2024).","DOI":"10.1038\/s41467-024-51993-4"},{"key":"77658_CR8","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1073\/pnas.1320962111","volume":"111","author":"C Valant","year":"2014","unstructured":"Valant, C. et al. Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist. Proc. Natl. Acad. Sci. USA 111, 4614\u20134619 https:\/\/doi.org\/10.1073\/pnas.1320962111 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77658_CR9","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm501535r","volume":"58","author":"Z Rankovic","year":"2015","unstructured":"Rankovic, Z. CNS drug design: balancing physicochemical properties for optimal brain exposure. J. Med. Chem. 58, 2584\u20132608 https:\/\/doi.org\/10.1021\/jm501535r (2015).","journal-title":"J. Med. Chem."},{"key":"77658_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/cn200100h","volume":"3","author":"AK Ghose","year":"2012","unstructured":"Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D. & Mallamo, J. P. Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery. ACS Chem. Neurosci. 3, 50\u201368 https:\/\/doi.org\/10.1021\/cn200100h (2012).","journal-title":"ACS Chem. Neurosci."},{"key":"77658_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","volume":"21","author":"TD McClure-Begley","year":"2022","unstructured":"McClure-Begley, T. D. & Roth, B. L. The promises and perils of psychedelic pharmacology for psychiatry. Nat. Rev. Drug Discov. 21, 463\u2013473 https:\/\/doi.org\/10.1038\/s41573-022-00421-7 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77658_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1021\/acs.chemrev.3c00375","volume":"124","author":"W Duan","year":"2024","unstructured":"Duan, W., Cao, D. M., Wang, S. & Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: psychedelics and non-hallucinogenic analogues as emerging antidepressants. Chem. Rev. 124, 124\u2013163 https:\/\/doi.org\/10.1021\/acs.chemrev.3c00375 (2024).","journal-title":"Chem. Rev."},{"key":"77658_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jnc.15540","volume":"162","author":"ST Slocum","year":"2022","unstructured":"Slocum, S. T., DiBerto, J. F. & Roth, B. L. Molecular insights into psychedelic drug action. J. Neurochem. 162, 24\u201338 https:\/\/doi.org\/10.1111\/jnc.15540 (2022).","journal-title":"J. Neurochem."},{"key":"77658_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cell.2022.12.020","volume":"186","author":"RH Gumpper","year":"2023","unstructured":"Gumpper, R. H. & Roth, B. L. SnapShot: psychedelics and serotonin receptor signaling. Cell 186, 232\u2013232 https:\/\/doi.org\/10.1016\/j.cell.2022.12.020 (2023).","journal-title":"Cell"},{"key":"77658_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.tips.2023.09.012","volume":"44","author":"IA Simon","year":"2023","unstructured":"Simon, I. A. et al. Ligand selectivity hotspots in serotonin GPCRs. Trends Pharm. Sci. 44, 978\u2013990 https:\/\/doi.org\/10.1016\/j.tips.2023.09.012 (2023).","journal-title":"Trends Pharm. Sci."},{"key":"77658_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107417","volume":"205","author":"GA Higgins","year":"2020","unstructured":"Higgins, G. A., Fletcher, P. J. & Shanahan, W. R. Lorcaserin: a review of its preclinical and clinical pharmacology and therapeutic potential. Pharm. Ther. 205, 107417. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107417 (2020).","journal-title":"Pharm. Ther."},{"key":"77658_CR17","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/s41591-022-02106-5","volume":"28","author":"Y He","year":"2022","unstructured":"He, Y. et al. Human loss-of-function variants in the serotonin 2C receptor associated with obesity and maladaptive behavior. Nat. Med. 28, 2537\u20132546 https:\/\/doi.org\/10.1038\/s41591-022-02106-5 (2022).","journal-title":"Nat. Med."},{"key":"77658_CR18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/14656566.2024.2373350","volume":"25","author":"GB Dell\u2019isola","year":"2024","unstructured":"Dell\u2019isola, G. B. et al. Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies. Expert Opin. Pharmacother. 25, 1121\u20131130 https:\/\/doi.org\/10.1080\/14656566.2024.2373350 (2024).","journal-title":"Expert Opin. Pharmacother."},{"key":"77658_CR19","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1038\/npp.2017.52","volume":"42","author":"VM Pogorelov","year":"2017","unstructured":"Pogorelov, V. M. et al. 5-HT2C agonists modulate schizophrenia-like behaviors in mice. Neuropsychopharmacology 42, 2163\u20132177 https:\/\/doi.org\/10.1038\/npp.2017.52 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"77658_CR20","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/cmdc.201500437","volume":"10","author":"J Cheng","year":"2015","unstructured":"Cheng, J. & Kozikowski, A. P. We need 2C but not 2B: developing serotonin 2C (5-HT2C) receptor agonists for the treatment of CNS disorders. ChemMedChem 10, 1963\u20131967 https:\/\/doi.org\/10.1002\/cmdc.201500437 (2015).","journal-title":"ChemMedChem"},{"key":"77658_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0269881116677104","volume":"31","author":"CE Canal","year":"2017","unstructured":"Canal, C. E. & Murnane, K. S. The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. J. Psychopharmacol. 31, 127\u2013143 https:\/\/doi.org\/10.1177\/0269881116677104 (2017).","journal-title":"J. Psychopharmacol."},{"key":"77658_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.06.012","author":"MK Jain","year":"2025","unstructured":"Jain, M. K. et al. The polypharmacology of psychedelics reveals multiple targets for potential therapeutics. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2025.06.012 (2025).","journal-title":"Neuron"},{"key":"77658_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1056\/NEJMp068265","volume":"356","author":"BL Roth","year":"2007","unstructured":"Roth, B. L. Focus on research-drug and valvular heart disease. N. Engl. J. Med 356, 6\u20139 https:\/\/doi.org\/10.1056\/NEJMp068265 (2007).","journal-title":"N. Engl. J. Med"},{"key":"77658_CR24","doi-asserted-by":"publisher","unstructured":"Dumotier, B. M. & Urban, L. Preclinical mitigation of 5-HT2B agonism-related cardiac valvulopathy revisited. J. Pharmacol. Tox. Met. 128. https:\/\/doi.org\/10.1016\/j.vascn.2024.107542. (2024).","DOI":"10.1016\/j.vascn.2024.107542"},{"key":"77658_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199708283370901","volume":"337","author":"HM Connolly","year":"1997","unstructured":"Connolly, H. M. et al. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337, 581\u2013588 https:\/\/doi.org\/10.1056\/NEJM199708283370901 (1997).","journal-title":"N. Engl. J. Med."},{"key":"77658_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM199809103391102","volume":"339","author":"H Jick","year":"1998","unstructured":"Jick, H. et al. A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N. Engl. J. Med. 339, 719\u2013724 https:\/\/doi.org\/10.1056\/NEJM199809103391102 (1998).","journal-title":"N. Engl. J. Med."},{"key":"77658_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa062222","volume":"356","author":"R Schade","year":"2007","unstructured":"Schade, R., Andersohn, F., Suissa, S., Haverkamp, W. & Garbe, E. Dopamine agonists and the risk of cardiac-valve regurgitation. N. Engl. J. Med. 356, 29\u201338 https:\/\/doi.org\/10.1056\/NEJMoa062222 (2007).","journal-title":"N. Engl. J. Med."},{"key":"77658_CR28","unstructured":"US Food and Drug Administration. Psychedelic Drugs: Considerations for Clinical Investigations. Guidance for Industry. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/psychedelic-drugs-considerations-clinical-investigations (2026)."},{"key":"77658_CR29","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1021\/acs.jmedchem.4c00082","volume":"67","author":"EM Rorsted","year":"2024","unstructured":"Rorsted, E. M., Jensen, A. A., Smits, G., Frydenvang, K. & Kristensen, J. L. Discovery and structure-activity relationships of 2,5-dimethoxyphenylpiperidines as selective serotonin 5-HT2A receptor agonists. J. Med Chem. 67, 7224\u20137244 https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00082 (2024).","journal-title":"J. Med Chem."},{"key":"77658_CR30","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1021\/acs.jmedchem.3c01961","volume":"67","author":"GB Varty","year":"2024","unstructured":"Varty, G. B. et al. Synthesis and structure-activity relationships of 2,5-dimethoxy-4-substituted phenethylamines and the discovery of CYB210010: a potent, orally bioavailable and long-acting serotonin 5-HT2 receptor agonist. J. Med. Chem. 67, 6144\u20136188 https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01961 (2024).","journal-title":"J. Med. Chem."},{"key":"77658_CR31","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","volume":"182","author":"K Kim","year":"2020","unstructured":"Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor. Cell 182, 1574\u20131588 https:\/\/doi.org\/10.1016\/j.cell.2020.08.024 (2020).","journal-title":"Cell"},{"key":"77658_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.abl8615","volume":"375","author":"DM Cao","year":"2022","unstructured":"Cao, D. M. et al. Structure-based discovery of nonhallucinogenic psychedelic analogs. Science 375, 403\u2013411 https:\/\/doi.org\/10.1126\/science.abl8615 (2022).","journal-title":"Science"},{"key":"77658_CR33","doi-asserted-by":"publisher","unstructured":"Gumpper, R. H. et al. The structural diversity of psychedelic drug actions revealed. Nat. Commun. 16 https:\/\/doi.org\/10.1038\/s41467-025-57956-7. (2025).","DOI":"10.1038\/s41467-025-57956-7"},{"key":"77658_CR34","doi-asserted-by":"publisher","unstructured":"Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25, 366\u2013428 https:\/\/doi.org\/10.1016\/S1043-9471(05)80049-7 (1995).","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"77658_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41594-018-0116-7","volume":"25","author":"JD McCorvy","year":"2018","unstructured":"McCorvy, J. D. et al. Structural determinants of 5-HT2B receptor activation and biased agonism. Nat. Struct. Mol. Biol. 25, 787\u2013796 https:\/\/doi.org\/10.1038\/s41594-018-0116-7 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77658_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/Ndt.S34433","volume":"9","author":"T Tenjin","year":"2013","unstructured":"Tenjin, T. et al. Profile of blonanserin for the treatment of schizophrenia. Neuropsych. Dis. Treat. 9, 587\u2013594 https:\/\/doi.org\/10.2147\/Ndt.S34433 (2013).","journal-title":"Neuropsych. Dis. Treat."},{"key":"77658_CR37","doi-asserted-by":"publisher","unstructured":"Chen, Z. C. et al. Flexible scaffold-based cheminformatics approach for polypharmacological drug design. Cell 187 https:\/\/doi.org\/10.1016\/j.cell.2024.02.034. (2024).","DOI":"10.1016\/j.cell.2024.02.034"},{"key":"77658_CR38","doi-asserted-by":"publisher","first-page":"8223","DOI":"10.1073\/pnas.1700891114","volume":"114","author":"A Ishchenko","year":"2017","unstructured":"Ishchenko, A. et al. Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody. Proc. Natl. Acad. Sci. USA 114, 8223\u20138228 https:\/\/doi.org\/10.1073\/pnas.1700891114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77658_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.str.2020.04.018","volume":"28","author":"MJ Robertson","year":"2020","unstructured":"Robertson, M. J., van Zundert, G. C. P., Borrelli, K. & Skiniotis, G. GemSpot: a pipeline for robust modeling of ligands into cryo-EM maps. Structure 28, 707\u2013716 https:\/\/doi.org\/10.1016\/j.str.2020.04.018 (2020).","journal-title":"Structure"},{"key":"77658_CR40","doi-asserted-by":"publisher","unstructured":"Zhou, Q. T. et al. Common activation mechanism of class A GPCRs. eLife 8. https:\/\/doi.org\/10.7554\/eLife.50279. (2019).","DOI":"10.7554\/eLife.50279"},{"key":"77658_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00213-013-3006-z","volume":"227","author":"AL Halberstadt","year":"2013","unstructured":"Halberstadt, A. L. & Geyer, M. A. Characterization of the head-twitch response induced by hallucinogens in mice detection of the behavior based on the dynamics of head movement. Psychopharmacology 227, 727\u2013739 https:\/\/doi.org\/10.1007\/s00213-013-3006-z (2013).","journal-title":"Psychopharmacology"},{"key":"77658_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107933","volume":"167","author":"AL Halberstadt","year":"2020","unstructured":"Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J. & Brandt, S. D. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology 167, 107933. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107933 (2020).","journal-title":"Neuropharmacology"},{"key":"77658_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/02698811251330741","volume":"39","author":"J Kehler","year":"2025","unstructured":"Kehler, J. & Lindskov, M. S. T. Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?. J. Psychopharmacol. 39, 889\u2013895 https:\/\/doi.org\/10.1177\/02698811251330741 (2025).","journal-title":"J. Psychopharmacol."},{"key":"77658_CR44","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 https:\/\/doi.org\/10.1021\/jm0306430 (2004).","journal-title":"J. Med. Chem."},{"key":"77658_CR45","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1021\/acs.jcim.1c00368","volume":"61","author":"S Gu","year":"2021","unstructured":"Gu, S., Smith, M. S., Yang, Y., Irwin, J. J. & Shoichet, B. K. Ligand strain energy in large library docking. J. Chem. Inf. Model 61, 4331\u20134341 https:\/\/doi.org\/10.1021\/acs.jcim.1c00368 (2021).","journal-title":"J. Chem. Inf. Model"},{"key":"77658_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10822-020-00277-2","volume":"34","author":"G Olanders","year":"2020","unstructured":"Olanders, G., Alogheli, H., Brandt, P. & Karl\u00e9n, A. Conformational analysis of macrocycles: comparing general and specialized methods. J. Comput. Aid Mol. Des. 34, 231\u2013252 https:\/\/doi.org\/10.1007\/s10822-020-00277-2 (2020).","journal-title":"J. Comput. Aid Mol. Des."},{"key":"77658_CR47","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1021\/ci900508k","volume":"50","author":"P Labute","year":"2010","unstructured":"Labute, P. LowModeMD-implicit low-mode velocity filtering applied to conformational search of macrocycles and protein loops. J. Chem. Inf. Model 50, 792\u2013800 https:\/\/doi.org\/10.1021\/ci900508k (2010).","journal-title":"J. Chem. Inf. Model"},{"key":"77658_CR48","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 https:\/\/doi.org\/10.1038\/s41589-020-0535-8 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"77658_CR49","doi-asserted-by":"publisher","unstructured":"Janicot, R. et al. Direct interrogation of context-dependent GPCR activity with a universal biosensor platform. Cell 187 https:\/\/doi.org\/10.1016\/j.cell.2024.01.028. (2024).","DOI":"10.1016\/j.cell.2024.01.028"},{"key":"77658_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41593-021-00971-w","volume":"25","author":"ZC Chen","year":"2022","unstructured":"Chen, Z. C. et al. Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties. Nat. Neurosci. 25, 39\u201349 https:\/\/doi.org\/10.1038\/s41593-021-00971-w (2022).","journal-title":"Nat. Neurosci."},{"key":"77658_CR51","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1126\/science.1232808","volume":"340","author":"D Wacker","year":"2013","unstructured":"Wacker, D. et al. Structural features for functional selectivity at serotonin receptors. Science 340, 615\u2013619 https:\/\/doi.org\/10.1126\/science.1232808 (2013).","journal-title":"Science"},{"key":"77658_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 https:\/\/doi.org\/10.1016\/j.jsb.2005.07.007 (2005).","journal-title":"J. Struct. Biol."},{"key":"77658_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/Nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 https:\/\/doi.org\/10.1038\/Nmeth.4169 (2017).","journal-title":"Nat. Methods"},{"key":"77658_CR54","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 https:\/\/doi.org\/10.1038\/nmeth.4193 (2017).","journal-title":"Nat. Methods"},{"key":"77658_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 https:\/\/doi.org\/10.1016\/j.jsb.2015.11.003 (2016).","journal-title":"J. Struct. Biol."},{"key":"77658_CR56","doi-asserted-by":"publisher","unstructured":"Lyu, J. K. et al. AlphaFold2 structures guide prospective ligand discovery. Science 384 https:\/\/doi.org\/10.1126\/science.adn6354. (2024).","DOI":"10.1126\/science.adn6354"},{"key":"77658_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 https:\/\/doi.org\/10.1002\/pro.3943 (2021).","journal-title":"Protein Sci."},{"key":"77658_CR58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 https:\/\/doi.org\/10.1107\/S0907444910007493 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"77658_CR59","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. Sect. D Struct. Biol. 75, 861\u2013877 https:\/\/doi.org\/10.1107\/S2059798319011471 (2019).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"77658_CR60","doi-asserted-by":"publisher","unstructured":"Rosignoli, S. & Paiardini, A. Boosting the full potential of PyMOL with structural biology plugins. Biomolecules 12 https:\/\/doi.org\/10.3390\/biom12121764. (2022).","DOI":"10.3390\/biom12121764"},{"key":"77658_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 https:\/\/doi.org\/10.1038\/s41586-024-07487-w (2024).","journal-title":"Nature"},{"key":"77658_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/cbdd.13388","volume":"93","author":"MT Muhammed","year":"2019","unstructured":"Muhammed, M. T. & Aki-Yalcin, E. Homology modeling in drug discovery: overview, current applications, and future perspectives. Chem. Biol. Drug Des. 93, 12\u201320 https:\/\/doi.org\/10.1111\/cbdd.13388 (2019).","journal-title":"Chem. Biol. Drug Des."},{"key":"77658_CR63","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins 55, 351\u2013367 https:\/\/doi.org\/10.1002\/prot.10613 (2004).","journal-title":"Proteins"},{"key":"77658_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"GM Sastry","year":"2013","unstructured":"Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput Aid Mol. Des. 27, 221\u2013234 https:\/\/doi.org\/10.1007\/s10822-013-9644-8 (2013).","journal-title":"J. Comput Aid Mol. Des."},{"key":"77658_CR65","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/nar\/gkr703","volume":"40","author":"MA Lomize","year":"2012","unstructured":"Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, 370\u2013376 https:\/\/doi.org\/10.1093\/nar\/gkr703 (2012).","journal-title":"Nucleic Acids Res."},{"key":"77658_CR66","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","volume":"610","author":"AL Kaplan","year":"2022","unstructured":"Kaplan, A. L. et al. Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity. Nature 610, 582\u2013591 https:\/\/doi.org\/10.1038\/s41586-022-05258-z (2022).","journal-title":"Nature"},{"key":"77658_CR67","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1016\/j.neuron.2022.08.006","volume":"110","author":"C Cao","year":"2022","unstructured":"Cao, C. et al. Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD. Neuron 110, 3154\u20133167 https:\/\/doi.org\/10.1016\/j.neuron.2022.08.006 (2022).","journal-title":"Neuron"},{"key":"77658_CR68","doi-asserted-by":"publisher","unstructured":"Liang, L. J. et al. A new variant of the colistin resistance gene MCR-1 with co-resistance to \u03b2-lactam antibiotics reveals a potential novel antimicrobial peptide. Plos Biol. 21 https:\/\/doi.org\/10.1371\/journal.pbio.3002433. (2023).","DOI":"10.1371\/journal.pbio.3002433"},{"key":"77658_CR69","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1126\/science.1136800","volume":"315","author":"BJ Frey","year":"2007","unstructured":"Frey, B. J. & Dueck, D. Clustering by passing messages between data points. Science 315, 972\u2013976 https:\/\/doi.org\/10.1126\/science.1136800 (2007).","journal-title":"Science"},{"key":"77658_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1098\/rspb.1983.0093","volume":"220","author":"JW Black","year":"1983","unstructured":"Black, J. W. P. L. Operational models of pharmacological agonism. Proc. R. Soc. Lond. Ser. B Biol. Sci. 220, 141\u2013162 https:\/\/doi.org\/10.1098\/rspb.1983.0093 (1983).","journal-title":"Proc. R. Soc. Lond. Ser. B Biol. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77658-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:59Z","timestamp":1789635779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77658-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77658"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77658-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C., S.W., H.L., J.Z. and L.T. have filed patents (PCT\/CN2025\/132646; PCT\/CN2025\/076535) through their institutions for the compounds reported in this study. The remaining authors (B.M., D.C., Y.C., J.Y., H.W., and Z.-J.L.) declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9874"}}